Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.

ClinicalTrials.gov 1 recruiting now early-phase tilt small index

Electronic Cigarette Related Lung Damage: early-phase trial registry

1 of 1 indexed Electronic Cigarette Related Lung Damage trials are currently recruiting, with more weight in Phase 1-2.

Corpus placement: #11,370 of 28,707 conditions by registered trial count.

1 US clinical trials · 1 currently recruiting · #11,370 of 28,707 conditions by registered trial count

Electronic Cigarette Related Lung Damage: 1 US clinical trial tracked, 1 recruiting.

Electronic Cigarette Related Lung Damage is the subject of 1 registered US clinical trials on ClinicalTrials.gov, 1 of them currently open to new participants. 0 are in Phase 3-4 (later-stage) and 1 in Phase 1-2 (earlier-stage). The most active sponsor is Y. Michael Shim, MD, running 1 of these trials.

Enrollment posture brief

Registry condition electronic-cigarette-related-lung-damage

OPEN 1 | RECR 100% | LATE 0 | EARLY 1 | RANK #11370 | SPON 1

Nearest open-share peer: Aortic Arch Aneurysm (100% recruiting · 5 trials)

Electronic Cigarette Rel (th…100%Ablation80%ACL Reconstruction80%Abuse, Drug60%Acceptability60%
Open-enrollment share among volume-matched conditions near Electronic Cigarette Related Lung Damage

Electronic Cigarette Related Lung Damage lists 1 open slots (100% of 1 indexed trials). Peers are matched on registered volume, not therapeutic-area browse lists. How peer matching works →

Key findings

What ClinicalTrials.gov does not surface for Electronic Cigarette Related Lung Damage on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.

  1. Electronic Cigarette Related Lung Damage is recruiting above its size-band peers.

    1 of 1 indexed trials (100%) are open to enrollment, against a 46.5% average across 27,806 conditions with fewer than 20 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.

Phase 21

Phase Distribution

PhaseTrial count
Phase 2 1

Top Sponsors

Named interventions

Most-linked intervention names on Electronic Cigarette Related Lung Damage records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.

Chest CT Diagnostic test
1 trials
Pulmonary Function Test Diagnostic test
1 trials
Cardiopulmonary Stress Test Diagnostic test
1 trials
Hyperpolarized xenon 129 Drug
1 trials

US sites by state

Facility locations filed on Electronic Cigarette Related Lung Damage trials. A trial with sites in several states counts in each.

Virginia 1 trials
North Carolina 1 trials

Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.

What to do with this Electronic Cigarette Related Lung Damage page

1 registered trials, 1 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.

  • 1 Electronic Cigarette Related Lung Damage trials are currently recruiting, check eligibility criteria before contacting a site. Browse recruiting trials
  • Y. Michael Shim, MD sponsors the most Electronic Cigarette Related Lung Damage trials on record, review their full trial history before evaluating a specific study. See Y. Michael Shim, MD's trials
  • Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide

Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Electronic Cigarette Related Lung Damage condition card totals 1 registered trials; most-linked intervention Chest CT; top US site state Virginia. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.